PE20001355A1 - 1,3-diamino-cetonas como inhibidores de proteasas - Google Patents
1,3-diamino-cetonas como inhibidores de proteasasInfo
- Publication number
- PE20001355A1 PE20001355A1 PE1999001311A PE00131199A PE20001355A1 PE 20001355 A1 PE20001355 A1 PE 20001355A1 PE 1999001311 A PE1999001311 A PE 1999001311A PE 00131199 A PE00131199 A PE 00131199A PE 20001355 A1 PE20001355 A1 PE 20001355A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- diamine
- het
- aralkyl
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11414398P | 1998-12-23 | 1998-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20001355A1 true PE20001355A1 (es) | 2001-01-28 |
Family
ID=22353596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1999001311A PE20001355A1 (es) | 1998-12-23 | 1999-12-23 | 1,3-diamino-cetonas como inhibidores de proteasas |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1140897A4 (zh) |
JP (1) | JP2002533452A (zh) |
AR (1) | AR021970A1 (zh) |
AU (1) | AU2713100A (zh) |
CO (1) | CO5180541A1 (zh) |
DZ (1) | DZ2976A1 (zh) |
HK (1) | HK1041690A1 (zh) |
PE (1) | PE20001355A1 (zh) |
WO (1) | WO2000039115A1 (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
WO2001034599A1 (en) | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Protease inhibitors |
AU1474801A (en) | 1999-11-10 | 2001-06-06 | Smithkline Beecham Corporation | Protease inhibitors |
JP2003513972A (ja) | 1999-11-10 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | プロテアーゼ阻害剤 |
CN1416346A (zh) | 2000-03-21 | 2003-05-07 | 史密丝克莱恩比彻姆公司 | 蛋白酶抑制剂 |
US6982263B2 (en) | 2001-06-08 | 2006-01-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Nitriles useful as reversible inhibitors of cysteine proteases |
WO2003075853A2 (en) | 2002-03-08 | 2003-09-18 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
EP1796793A4 (en) * | 2004-09-07 | 2009-08-05 | Smithkline Beecham Corp | NEW CONNECTIONS |
WO2006076575A2 (en) * | 2005-01-13 | 2006-07-20 | Bristol-Myers Squibb Company | Substituted biaryl compounds as factor xia inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DZ2285A1 (fr) * | 1996-08-08 | 2002-12-25 | Smithkline Beecham Corp | Inhibiteurs de protéase de la cystéine. |
JP2001525809A (ja) * | 1997-05-08 | 2001-12-11 | スミスクライン・ビーチャム・コーポレイション | プロテアーゼ阻害剤 |
-
1999
- 1999-12-16 CO CO99078651A patent/CO5180541A1/es not_active Application Discontinuation
- 1999-12-21 AR ARP990106647A patent/AR021970A1/es unknown
- 1999-12-21 JP JP2000591026A patent/JP2002533452A/ja not_active Withdrawn
- 1999-12-21 AU AU27131/00A patent/AU2713100A/en not_active Abandoned
- 1999-12-21 EP EP99968936A patent/EP1140897A4/en not_active Withdrawn
- 1999-12-21 WO PCT/US1999/030602 patent/WO2000039115A1/en not_active Application Discontinuation
- 1999-12-22 DZ DZ990276A patent/DZ2976A1/xx active
- 1999-12-23 PE PE1999001311A patent/PE20001355A1/es not_active Application Discontinuation
-
2002
- 2002-02-19 HK HK02101209.3A patent/HK1041690A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CO5180541A1 (es) | 2002-07-30 |
EP1140897A4 (en) | 2002-04-03 |
DZ2976A1 (fr) | 2004-03-15 |
AU2713100A (en) | 2000-07-31 |
HK1041690A1 (zh) | 2002-07-19 |
WO2000039115A1 (en) | 2000-07-06 |
AR021970A1 (es) | 2002-09-04 |
JP2002533452A (ja) | 2002-10-08 |
EP1140897A1 (en) | 2001-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20001340A1 (es) | 4-amino-azepan-3-ona como inhibidores de proteasas | |
LU91069I2 (fr) | Aprepitant et ses sels pharmaceutiquement acceptables (EMEND) | |
PE2799A1 (es) | Lactamas e imidas heterociclicas de aralquilo y aralquilideno | |
PE99198A1 (es) | Inhibidores de proteasas | |
FI865037A (fi) | Mikrobicida kompositioner. | |
PE110899A1 (es) | Derivados de acidos ariloxiarilsulfonilamino hidroxamicos | |
DE69133299D1 (de) | Aminosulfonylcarbamate | |
DK1409467T3 (da) | N-acylsphingosinglucosyltransferase-inhibitor | |
PE20060215A1 (es) | 4-fenilamino-quinazolin-6-il-amidas | |
PT788356E (pt) | Metodo e composicoes para a inibicao de proteina-quinases. | |
PE20021004A1 (es) | Derivados de piperidina como inhibidores de la ccr5 | |
PE20001355A1 (es) | 1,3-diamino-cetonas como inhibidores de proteasas | |
PE68599A1 (es) | Inhibidores de proteasas | |
PE20000435A1 (es) | Compuestos azapoliciclicos condensados con arilo | |
RS49965B (sr) | Supstituisani bisindolmaleimidi za inhibiciju ćelijske proliferacije | |
CO4650039A1 (es) | Benzotiofenos amorfos, procedimientos de preparacion y procedimientos de uso | |
PE20001486A1 (es) | Compuestos etereos anular de 7 a 14 miembros como inhibidores de proteasas | |
PE20001564A1 (es) | 1,3-dioxepin-5-ona con un anillo de 7 miembros como inhibidores de proteasas | |
CO5180536A1 (es) | Inhibidores de proteasas catepsina | |
ATE34173T1 (de) | Thiazolderivate als h2-rezeptor-antagonisten. | |
RU2007111957A (ru) | Пиперидиновое производное или его фармацевтически приемлемая соль | |
KR920002569A (ko) | 치환 피페리딘 및 그의 콜레스테롤 합성 억제제로서의 용도 | |
PE20030728A1 (es) | Compuestos de isocromano | |
ES2192342T3 (es) | 2-(2,6-dioxo-3-fluoropiperidin-3-il)-isoindolinas sustituidas y su uso para reducir los niveles de tnfalfa. | |
CO5280091A1 (es) | Inhibidores de proteasas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |